IGF2BP2 (Insulin-like Growth Factor 2 mRNA-Binding Protein 2), also known as IMP2 (IGF2 mRNA-Binding Protein 2), is a member of the IGF2BP family of RNA-binding proteins. The IGF2BP family consists of three paralogs (IGF2BP1/IMP1, IGF2BP2/IMP2, and IGF2BP3/IMP3) that regulate RNA localization, stability, and translation. IGF2BP2 is particularly notable for its roles in metabolism, development, and its involvement in neurodegenerative diseases and cancer.
IGF2BP2 is a 609-amino acid protein with a molecular weight of approximately 66 kDa. The protein contains multiple functional domains:
¶ RNA-Binding Domains
-
Six KH domains (hnRNP K Homology domains)
- KH domains I-VI are conserved RNA recognition motifs
- Each domain consists of approximately 65 amino acids
- Form a quasi-RNA recognition motif (quasi-RRM)
- Bind to specific sequences in target mRNAs
-
N-terminal Region
- Contains nuclear localization signals (NLS)
- Regulates nucleocytoplasmic shuttling
- Protein-protein interaction motifs
-
C-terminal Region
- Mediates interactions with other RNA-binding proteins
- Contains regions for granule localization
- Regulatory sequences
- KH domains 2-4 are critical for RNA binding
- The spacing between KH domains determines target specificity
- Post-translational modifications regulate protein function
- Forms ribonucleoprotein (RNP) complexes
IGF2BP2 is a versatile RNA-binding protein with multiple regulatory functions:
mRNA Localization
- Binds to IGF2 (Insulin-like Growth Factor 2) mRNA
- Regulates beta-actin (ACTB) mRNA localization
- Controls transcript distribution in cells
- Important for neuronal morphogenesis
Translation Regulation
- Functions as a translation enhancer or inhibitor depending on context
- Promotes translation of target mRNAs
- Can repress translation through 5' UTR binding
- Regulates protein synthesis in response to cellular signals
mRNA Stability
- Protects target mRNAs from degradation
- Binds to AU-rich elements (AREs) in 3' UTRs
- Regulates RNA half-life
- Affects gene expression post-transcriptionally
Cell Growth and Proliferation
- Promotes cell cycle progression
- Enhances cell growth and size
- Regulates proliferation in development and disease
- Oncogenic functions in cancer
Metabolism
- Highly expressed in pancreatic beta cells
- Regulates insulin secretion
- Modulates glucose metabolism
- IGF2BP2 variants associated with type 2 diabetes risk
Development
- Expressed during embryonic development
- Important for neuronal differentiation
- Regulates axon guidance
- Essential for proper brain development
Stress Granules
- IGF2BP2 localizes to stress granules under cellular stress
- Part of the RNA granule family including processing bodies (P-bodies)
- Stores translationally repressed mRNAs
- Dynamic assembly/disassembly in stress response
DNA Damage Response
- Associates with DNA damage response proteins
- May regulate transcripts involved in DNA repair
- Links RNA metabolism to genome stability
IGF2BP2 has multifaceted roles in Alzheimer's disease pathogenesis:
Amyloid-beta Metabolism
- Altered expression in AD brain regions
- May affect APP processing indirectly
- Links metabolic dysfunction to AD pathology
Tau Pathology
- IGF2BP2 can bind to MAPT (tau) mRNA
- May influence tau expression levels
- Potential role in tauopathies
Synaptic Function
- Regulates synaptic RNA localization
- Important for synaptic plasticity
- Dysregulation affects memory and learning
Therapeutic Implications
- Modulating IGF2BP2 may have neuroprotective effects
- RNA-based therapeutic approaches being explored
- Metabolic pathway links provide novel targets
Alpha-synuclein Regulation
- IGF2BP2 may bind to SNCA (alpha-synuclein) mRNA
- Potential to modulate alpha-synuclein expression
- Links RNA metabolism to Lewy body pathology
Mitochondrial Function
- Regulates transcripts involved in mitochondrial biology
- May affect mitochondrial dynamics
- Relevant to PD mitochondrial dysfunction
Dopaminergic Neuron Vulnerability
- Expressed in dopaminergic neurons
- May affect neuronal survival pathways
- Stress granule pathology in PD models
RNA Granule Pathology
- IGF2BP2 aggregates in ALS models
- Part of the RNA granule abnormalities in ALS
- May sequester normal RNA-binding proteins
TDP-43 Pathology
- Interactions with TDP-43 proteinopathy
- Both proteins in RNA granules
- Shared mechanisms in ALS-FTD spectrum
Motor Neuron Dysfunction
- Essential for motor neuron development
- Altered expression in ALS spinal cord
- May contribute to RNA metabolism defects
- Huntington's Disease: Potential roles in mutant huntingtin RNA metabolism
- Frontotemporal Dementia: RNA granule involvement
- Multiple Sclerosis: Altered expression in demyelinating disease
RNA-Targeting Approaches
- Antisense oligonucleotides targeting IGF2BP2
- Small molecules modulating RNA-protein interactions
- siRNA/shRNA approaches
Metabolic Modulation
- Compounds affecting IGF2BP2 expression
- Metabolic pathway drugs with secondary effects
- Gene therapy approaches
- CSF IGF2BP2 levels as disease biomarker
- Expression changes in blood
- Correlates with disease progression
Studying IGF2BP2 in neurodegeneration:
- RNA immunoprecipitation (RIP): Identify target mRNAs
- CLIP-seq: Map RNA-protein binding sites
- Polysome profiling: Assess translation efficiency
- Stress granule analysis: Localization studies
¶ Interactions and Pathways
IGF2BP2 interacts with multiple partners:
| Partner |
Interaction Type |
Functional Consequence |
| IGF2 mRNA |
Direct binding |
Localization, translation |
| ACTB mRNA |
Direct binding |
Cytoskeletal regulation |
| p53 |
Protein interaction |
Stress response |
| MDM2 |
Ubiquitination |
Protein stability |
| G3BP1 |
Stress granules |
RNA granule formation |